Mendelspod Podcast
Episodes
How Personalized is Personalized Medicine? Krister Wennerberg on FIMM’s Individualized Systems Medicine
22 Sep 2016
Contributed by Lukas
Most of the time, when we talk about personalized medicine, it’s not that personalized. What we’re really talking about is population-based medic...
Digital PCR Opens Up New Liquid Biopsy Opportunity in Melanoma Treatment: David Polsky, NYU
20 Sep 2016
Contributed by Lukas
The history of science is also a history of toolmaking. And nowhere is this more true than in modern biology. New instruments in the lab allow biolo...
Erica Ramos on Her Pioneering Role as Genetic Counselor for Industry
14 Sep 2016
Contributed by Lukas
For the next installment of our series on genetic counseling, we’re joined by Erica Ramos. She’s the president-elect of the National Society of G...
August 2016 with Nathan and Laura
01 Sep 2016
Contributed by Lukas
It’s the end of summer and end of another month. Joining us to discuss the genomics headlines of August are Laura Hercher and Nathan Pearson.A rece...
A Maniacal Commitment to Science: Peering into Regeneron’s Genetics Center with Jeff Reid
18 Aug 2016
Contributed by Lukas
Today we feature a pharma company that has been around for some time but recently getting more media coverage for the impressive scale of their new ge...
The Days of Miracle and Wonder: Laura Hercher on Genetic Counseling, Part 2
30 Jul 2016
Contributed by Lukas
We often hear at conferences that there are too few genetic counselors. And that this bottleneck is constraining the delivery and promise of genomic ...
The Days of Miracle and Wonder: Laura Hercher on Genetic Counseling, Part 1
30 Jul 2016
Contributed by Lukas
They’ve been called the “unsung heroes” of our age. They are primarily women. And when the trend for most of us is to become specialists, they...
A Precision Medicine Platform Comes of Age: Jonathan Hirsch, Syapse
21 Jul 2016
Contributed by Lukas
Today’s show with Jonathan Hirsch, the President and co-founder of Syapse begins a couple years ago. We first featured him on the program in January...
FDA’s Liz Mansfield on New NGS Guidances
19 Jul 2016
Contributed by Lukas
On July 6th, as part of the President’s Precision Medicine Initiative, the FDA issued two new draft guidances for the oversight of next gen sequenci...
How Is the Brexit Impacting Genomics? with Clare Turnbull and Hadyn Parry
12 Jul 2016
Contributed by Lukas
Today's guests have been separately on the program recently. And we've asked them, both Brits, to come back on for a discussion of the Brexit. Clare...
It’s Not Really Bulls and Bears: John Carroll on His New Gig, the Brexit, and a New Metaphor for the Market
07 Jul 2016
Contributed by Lukas
John Carroll has been the editor-in-chief at Fierce Biotech for thirteen years. Now he's moved to a new gig. Two weeks ago, he and a former colleag...
June 2016 with Nathan and Laura: GMO Labeling, Misspelling CRISPR, Sequenom Patent Loss, SmidgIon
05 Jul 2016
Contributed by Lukas
Today's show was recorded July 1st, the first day that Vermont’s GMO labeling law went into effect. Just how big a win was this for the anti-GMO cr...
Know Then Thyself: Kari Stefansson, deCODE genetics
30 Jun 2016
Contributed by Lukas
Kari Stefansson is a name well known in the field of human genetics. His founding of deCODE genetics in his native Iceland in 1996 took our field in...
Sequenom Patent Loss a Threat to Personalized Medicine, Says Kevin Noonan
29 Jun 2016
Contributed by Lukas
It’s a non-decision with big implications. On Monday, the Supreme Court turned down an appeal by Sequenom in their patent case with Ariosa. The re...
Bringing Home Some Diagnostics Gold: Brad Gray, NanoString Show How It’s Done
24 Jun 2016
Contributed by Lukas
You hear it everywhere. And it’s getting old. That "diagnostics is a tough slog.” That it’s the “redheaded stepchild of healthcare.”And ...
Mukherjee Mess-up, the Secret Harvard Meeting, and Success in Gene Therapy: May 2016 with Nathan and Laura
06 Jun 2016
Contributed by Lukas
Today we look back on the genomics headlines over the past month (and a few days). To do this we’re joined by our regular commentators, Nathan Pear...
When Do We Move to Population Based Cancer Screening for Those with High Genetic Risk? Josh Schiffman, U of U
24 May 2016
Contributed by Lukas
Last year when we were promised a soon-to-be-on-the-market, pan cancer, genetic based screening test, many of us were taken aback at the hubris. Not ...
The Solid Future of Liquid Biopsies with Michael Nall, Biocept
19 May 2016
Contributed by Lukas
There’s been lots in the news this past year about liquid biopsies—those non-invasive tests which locate biomarkers in a vial of blood. Much of t...
Genomics Is Oversubscribed, Says Creator of BLAST
12 May 2016
Contributed by Lukas
One of the original Celera team that worked on the Human Genome Project, Gene Myers is now setting up the new Center for Systems Biology at the Max Pl...
With 10K Genomes Sequenced, Genomics England in High Gear: Clare Turnbull, Clinical Lead
05 May 2016
Contributed by Lukas
We’ve heard on the program over the past few years that genomic medicine will probably take off first in a country with a centralized health service...
April 2016 with Nathan and Laura: Big Money, More CRISPR Studies, Genomic Superheroes, and a Pot Chaser
02 May 2016
Contributed by Lukas
This month we saw Big Money being infused into genomics and other life science research projects. There’s no question that science is big business,...
A Sneak Peek into the Future of Clinical Genomics with Ben Solomon, Inova
28 Apr 2016
Contributed by Lukas
We hear from some that soon each baby's genome will be sequenced at birth. This vast amount of genomic information will be stored in a person's medic...
Preprints and the Future of Science Publishing with Jason Hoyt, PeerJ
11 Apr 2016
Contributed by Lukas
A renewed effort has been underway by leading biologists this year to persuade their colleagues to preprint. This is the posting of a paper to an ope...
Flipping Drug Development Upside Down: Niven Narain, BERG Health
06 Apr 2016
Contributed by Lukas
The promise of rational drug design has driven pharma companies for years. The history of the industry has been one of trial and error, or “guess a...
March 2016 with Nathan and Laura: Genomic Jenga and the Creator, the Anti-Abortion Lobby and Genetic Testing, and Theranos, Again
01 Apr 2016
Contributed by Lukas
Which company offers the gold standard of sequencing? Nathan starts us out with a metaphor to compare linked reads with real long reads. Then it’s...
Medicine and the Limits of Science with Michel Accad, MD
30 Mar 2016
Contributed by Lukas
Are drug prices really too high? If so, how do we bring them down? Is precision medicine and the use of molecular profiles really making a differenc...
How Good are Linked Reads? Serge Saxonov, 10X Genomics
15 Mar 2016
Contributed by Lukas
When 10X Genomics launched their GemCode sequencing instrument at last year’s AGBT conference, what they offered seemed too good to be true. 10X wa...
A Home Run on the First Hit: PacBio’s Jonas Korlach
08 Mar 2016
Contributed by Lukas
Jonas Korlach is a natural storyteller—a rare trait in a scientist who is more comfortable presenting data than talking of himself. Jonas is the c...
Digital Pathology at Scale: Epic Sciences Takes CTC Technology to the Next Level
03 Mar 2016
Contributed by Lukas
It’s the beginning of the age of liquid biopsies, when less invasive, regular blood draws will provide more information than the occasional solid ti...
February 2016: Mosquitos, Preprints, and that Rocking White House Summit
01 Mar 2016
Contributed by Lukas
It’s time again to look back on another month with Nathan and Laura. This is a public episode. If you'd like to discuss this with other subscribers ...
BioNano Genomics Stakes Out Sequencing Territory as They Discover Lots of De Novo Variants in Reference Genome Projects
25 Feb 2016
Contributed by Lukas
If you attended or followed the recent AGBT conference about all things sequencing, you probably saw a few BioNano Genomics t-shirts with the slogan, ...
Is Oxitec Ready to Scale as Governments Seek Options to Control the Zika Virus?
23 Feb 2016
Contributed by Lukas
With constant news topping the headlines about the Zika virus, a synthetic biology company out of Oxford England, Oxitec, has been getting some good p...
Human Genome Turns 15: Mike Hunkapiller
04 Feb 2016
Contributed by Lukas
We’re all familiar with the announcement in the year 2000 by US President, Bill Clinton, and the UK’s Prime Minister, Tony Blair, that scientists ...
January 2016: Landergate, Grail, and Cancer Moonshot
01 Feb 2016
Contributed by Lukas
“It being the month of Hypeuary, go hither through break in yonder wall called LanderGate, and thou wilt be on route to reach the Grail. Drink from...
Frontiers of Sequencing: Putting Long Reads and Graph Assemblies to Work
28 Jan 2016
Contributed by Lukas
OK, so we get it. Long read sequencing technology is cool. But how cool? Is it another great player on the field, or does it change the game altogethe...
Why Drugs Are Priced So High and Diagnostics So Low
21 Jan 2016
Contributed by Lukas
Pharma companies face escalated flack over high drug prices. Meanwhile the diagnostics industry toils away at comparative pennies to the dollar. This...
Who Is John Ioannidis?
14 Jan 2016
Contributed by Lukas
It’s now been over ten years since John Ioannidis published his now famous paper, Why Most Published Research Findings Are False. What response ...
Cancer: Year in Review 2015 with Anna Barker
30 Dec 2015
Contributed by Lukas
As we begin the countdown to the new year, we take a look back at 2015 in cancer research, treatment and prevention. Mendelspod is increasingly becom...
Sci-Fi Author Kim Stanley Robinson Talks Life Science 2015
22 Dec 2015
Contributed by Lukas
At the end of the year our goal is to bring the audience some unusual programming, some new outside perspectives on the topics we cover. As with last ...
Yes to FDA Regulation of LDTs, But We Need a New Framework, Says David Spetzler
03 Dec 2015
Contributed by Lukas
We set up an interview with David Spetzler, the CSO of Caris Life Sciences, to hear about some promising new liquid biopsy tests they are developing. ...
Genomics and the Cloud Going Through “a Second Puberty,” says AWS’ Angel Pizarro
24 Nov 2015
Contributed by Lukas
Angel Pizarro has watched as genomics and cloud computing have grown up together. Formerly a bioinformatics director at University of Pennsylvania, ...
Hot Biotech Market Neglects Stem Cell Therapies, Says CIRM's Neil Littman
18 Nov 2015
Contributed by Lukas
In 2004, California voters approved Prop 71 to fund the field of stem cell research by setting up the California Institute of Regenerative Medicine, o...
The Future of Diagnostics Reimbursement with Bruce Quinn
12 Nov 2015
Contributed by Lukas
We toss the term "precision medicine" around with ease today, and yet payers continue to refuse to pay for diagnostic tests.These are tests that might...
Framingham for the Modern Era: Josie Briggs on the Precision Medicine Initiative
04 Nov 2015
Contributed by Lukas
Josie Briggs is Director of the National Center for Complementary and Integrative Health (NCCIH) at the NIH. She is also currently serving as interim...
Do Alternate Proposals to Regulate LDTs Stand a Chance?
29 Oct 2015
Contributed by Lukas
As the FDA works away on final guidance for regulating LDTs, various professional groups unhappy with the course of the FDA have put together and hurr...
Does the Reproducibility Project in Cancer Biology Offer a Model for a New Kind of Science Auditing?
27 Oct 2015
Contributed by Lukas
Here on the show, we’ve talked about the lack of reproducibility for much of biological research. We’ve bandied around various percentages--is it...
After CMS Announcement, Peter Maag and CareDx Fight for Life
22 Oct 2015
Contributed by Lukas
By listening to him, you wouldn’t know that Peter Maag, the CEO of CareDx, was fighting to keep his company from the brink. We booked Peter for the ...
The Goal Is De Novo Assembly in the Clinic, Says Jim Lupski, Baylor
20 Oct 2015
Contributed by Lukas
Today’s story is one of a personal quest, of groundbreaking science, and the creation of a new movement in human genomics.Jim Lupski is a professor ...
Cliff Reid Says New Supersequencer Leads the Pack for High Throughput Clinical Sequencing
16 Oct 2015
Contributed by Lukas
Cliff Reid, CEO of Complete Genomics, is back on the conference circuit, touting a new product. After years of building his company to do sequencing ...
Defending the Value of Biotech Innovation in California: Sara Radcliffe, CLSA
09 Oct 2015
Contributed by Lukas
Earlier this year, the California Life Sciences Association (CLSA) launched, becoming the first statewide policy and advocacy group for biotech. The n...
Long Read Sequencing Dramatically Improves Blood Matching: Steven Marsh, Anthony Nolan Institute
06 Oct 2015
Contributed by Lukas
One of the popular questions on the program this past year is how those doing sequencing decide between the quality of Pacific Bioscience's long reads...
The World of DIY Genomics with K T Pickard
01 Oct 2015
Contributed by Lukas
K Thomas Pickard is not at all into sports cars. So when he hit midlife crisis, it wasn’t a Porsche or a golf club membership that would reenergiz...
Sequencing in Space: Chris Mason, Cornell
24 Sep 2015
Contributed by Lukas
The last time we talked with Chris Mason of Weill Cornell Medical College the Supreme Court had just decided the controversial Myriad gene patent case...
Is the Future of Biology a Return to Chemistry? Carolyn Bertozzi, Stanford
22 Sep 2015
Contributed by Lukas
Classes for the school year begin this week at Stanford University. New to the faculty is Carolyn Bertozzi, an American chemist who made her name a...
Going Beyond the $1,000 Genome with Mark Gerstein
17 Sep 2015
Contributed by Lukas
Though recent guests at Mendelspod say we're not quite to the $1,000 genome, we're close enough to use that benchmark in genomics discussions. But wh...
Creating the Foundation of Genomics: Marc Salit, NIST
10 Sep 2015
Contributed by Lukas
What is a human genome? Well it’s the three billion letters of our DNA. But how is it measured? How do we know when we have it accurately represe...
Still Unhappy with FDA’s Plan to Regulate LDTs, Professional Lab Groups Go Direct to the Senate
08 Sep 2015
Contributed by Lukas
It's no secret that America's molecular testing laboratories by and large are worried that the FDA's plan to regulate laboratory developed tests, or L...
A Diagnostic Success Story with Alka Chaubey, Greenwood Genetic Center
03 Sep 2015
Contributed by Lukas
Diagnostics can be a tough business. The FDA is making a strong push to bring more oversight. Obtaining reimbursement can be outright Sisyphean. An...
With Two New Easy-to-Use Sequencing Instruments, Thermo Readies for Primetime in the Clinic
01 Sep 2015
Contributed by Lukas
The race to the $1,000 genome has been full of breathtaking advances, one after the other. But is next gen sequencing reaching maturity? Will there be...
Here's Looking at Euclid
28 Aug 2015
Contributed by Lukas
A slow week in life science left us scratching our heads about the purpose of some new studies.The first, a major project to study the microbes in abo...
Is This the Future of Clinical Trials for Cancer? Stanley Hamilton on the NCI’s New MATCH Trial
27 Aug 2015
Contributed by Lukas
It’s taken some time, but the NCI is finally sponsoring a big time clinical trial for cancer where the patients are organized by the genomic pathway...
Brian Kennedy and Aubrey de Grey on their Converging Approaches to Aging Research
25 Aug 2015
Contributed by Lukas
Last week we attended the 2015 Rejuvenation Biotechnology Conference where we heard about the latest developments in aging research.We were fortunate ...
The Business of Aging and Three Reasons Why the FDA Drug Approval Rate Is So High
21 Aug 2015
Contributed by Lukas
We're back in the office after a fabulous vacation, and ready to have some fun. It's Friday, and time for Gene and Tonic.Yes, we celebrate the news t...
New York Genome Center’s Nathan Pearson on Public Outreach for Genomics
19 Aug 2015
Contributed by Lukas
Nathan Pearson, formerly a genome scientist at Ingenuity and Knome, has been doing public outreach for genomics at the New York Genome Center for abou...
Tim Triche on Using Arrays for Cancer Research
31 Jul 2015
Contributed by Lukas
We recently interviewed cancer researcher Tim Triche from Children's Hospital Los Angeles. Tim had two main points: First, microarrays are still a ver...
Thermo’s Chris Linthwaite on Sequencing the Ebola Virus and the Future of Public Health
28 Jul 2015
Contributed by Lukas
Major outbreaks of deadly viruses, such as the recent spread of Ebola in Northern Africa, are nothing new on planet earth. What is new is the technol...
A Tool to Strengthen the Voice of Science in Online Journalism
23 Jul 2015
Contributed by Lukas
Emmanuel Vincent is the founder of Climate Feedback, a project which includes a new tool for scientists to comment directly on climate science news. T...
Father of Child with Rare Disease Says Science Equals Medicine
21 Jul 2015
Contributed by Lukas
Matt Might came knocking on the door of genomic medicine out of pure necessity. After a four year diagnostic odyssey that led them to Duke University,...
Bina CEO Details Secret to Success in NGS Informatics
17 Jul 2015
Contributed by Lukas
Last year, pharma giant Roche went on a buying spree, picking up one company after another. In December, when it was announced they had bought out Bi...
Cancer Researcher Tim Triche on the Staying Power of Microarrays
14 Jul 2015
Contributed by Lukas
In the second part of our interview with Tim Triche, Director of the Personalized Medicine Center at Children’s Hospital Los Angeles, Tim says that ...
Want Answers? Look to the Non-Coding Region of the Genome, Says Cancer Researcher, Tim Triche
09 Jul 2015
Contributed by Lukas
Listen to Tim Triche from Children's Hospital Los Angeles for very long and you’ll get excited again about cancer research. I couldn’t stop listen...
Ivan Oransky on Today's Retraction Boom
07 Jul 2015
Contributed by Lukas
When science journalist Ivan Oransky co-founded Retraction Watch, a blog with the express purpose of making scientific retractions more public, he did...
Genomics-Palooza, Diagnostics Fraud, and Biblical Prophets on the Future of Biotech
26 Jun 2015
Contributed by Lukas
What a week for Americans . . . What a week for genomics!The Supreme Court rulings that Americans can keep their Obamacare and can all get married - n...
Ethical Issues around Editing Human Germline for the Future. Today It's about Plants and Animals, Says NYU's Art Caplan
24 Jun 2015
Contributed by Lukas
Art Caplan is a prodigious writer on the topic of medical ethics. How prodigious? How about thirty-two books and over 700 peer reviewed papers on ethi...
We Got Research, PCSK9 Inhibitors, and Clinical Trials for Religion
19 Jun 2015
Contributed by Lukas
The international BIO convention is all about seduction. All fifty states sent representatives to Philly this week to make the case that their state...
The Multi-Platform Approach to Clinical Sequencing with Bobby Sebra, Icahn School
15 Jun 2015
Contributed by Lukas
Before Bobby Sebra became the Director of Technology Development at the Icahn School of Medicine at Mt Sinai in New York he worked at Pacific Bioscien...
So That Happened, The Mad Genius, and Selling SynBio
12 Jun 2015
Contributed by Lukas
It’s a week of finding out again what we already knew. First that a nobel laureate can also be a total ***hole. And second that creative people re...
Summer Genomics Festival, the Other Sports Genes, and Brain Surgery for Fruit Flies
05 Jun 2015
Contributed by Lukas
Gene and Tonic for June 5, 2015What does genomics have to do with a hippie rock music event? A few things. Find out in today’s humorous preview...
The Sports Genes with Jeremy Koenig, Athletigen
04 Jun 2015
Contributed by Lukas
Jeremy Koenig is a molecular biologist and an athlete. His interest in both led him to found a new direct-to-consumer genetic testing company called A...
Woodstock for Genomics? Richard Lumb and Carl Smith on this Month’s Festival
02 Jun 2015
Contributed by Lukas
If you haven’t already, check out the inaugural Festival of Genomics being held in Boston later this month. This is a public episode. If you'd like ...
Geneticists Anonymous, the Sad State of Science Journalism, and New Kids on the Helix
29 May 2015
Contributed by Lukas
Gene and Tonic: May 29, 2015Did you hear? The Age of Genomics has come to an end. According to science journalist, David Dobbs, after 110 years of...
The 9 Billion People Problem: Rod Wing on Plant Genomics
27 May 2015
Contributed by Lukas
By 2050, there will be 9 billion people on the planet. What will they eat?This is the question that led Rod Wing, Director of the Arizona Genomics Ins...
Should We Hold Back the Reins on Biotechnology? with Chris Gunter
22 May 2015
Contributed by Lukas
A very unique biotechnology event took place this week.BEINGS 2015, or the Biotech and the Ethical Imagination Global Summit, was held at The Tabernac...
Are We Ready to Trust Liquid Biopsies? with Milena Cankovic, Henry Ford Hospital
19 May 2015
Contributed by Lukas
If you followed the news from the recent show of the American Association for Cancer Research (AACR), no doubt you heard about the exciting potential ...
Gene and Tonic: Boxing for Cancer, Dubious Correlations, and When Should a Researcher Retire
15 May 2015
Contributed by Lukas
In a keynote talk this week for the online Genetics and Genomics conference, computational biology whiz, John Quackenbush, listed some pretty wild co...
New Patient Focused Genome Magazine Signing up Many Doctors Too
12 May 2015
Contributed by Lukas
Just as biomedical research is experiencing a surge of translation into clinical application, so too must the stories of this research and its impact ...
Gene and Tonic: The Decline of Pseudoscience, An Atheist for President, and What to Do with a Sexist Reviewer
08 May 2015
Contributed by Lukas
The New Republic argued in a pice entitled, "The Decline of Pseudoscience," this week that now that the so called "natural" living industry has gone ...
Gene and Tonic: Sexism in Science, How to Spend an NIH Budget Increase, How Not to Spend It
01 May 2015
Contributed by Lukas
Janitors have had a terribly busy time this week cleaning up all those jaws that were dropped on floors of research labs everywhere around the country...
Participation in Genomics Research a 21st Century Public Good, Says Paul Billings of Omicia
15 Apr 2015
Contributed by Lukas
Pharma companies have always had their chief medical officers (CMOs). Now, as the diagnostics industry grows, many kinds of life science companies ar...
Gene and Tonic: Competition for 23andMe, Four Tips for Attending AACR 2015, and "Swab Stories"
10 Apr 2015
Contributed by Lukas
An Old New DTC Co. on the MoveLet’s start with a bit of trivia. What company has resorted to selling genetic ancestry testing online direct to con...
Improving the Backbone of Clinical Genomics : Valerie Schneider, NCBI
07 Apr 2015
Contributed by Lukas
When President Bill Clinton stood with Francis Collins and Craig Venter in 2001 to announce the sequencing of the genome, the genome wasn’t really d...
Gene and Tonic: The ACA Turns Five, Ten Reasons to Have Your Genome Sequenced, and Humbled by the Ancients
03 Apr 2015
Contributed by Lukas
Actually there was no news this week. It turns out the whole industry took the week off to watch the stunning Ken Burns documentary on cancer. No,...
Behind the Sequencing Bench with Dale Yuzuki
31 Mar 2015
Contributed by Lukas
Will tech companies like Google and Apple be good at life science applications? We pursue this question today with Dale Yuzuki, the avid life science ...
Gene and Tonic: The Tenth Commandment of Science, Icelandic Treasure, and TechBio Babies
27 Mar 2015
Contributed by Lukas
We were off last week, so there’s plenty to talk about. This is a public episode. If you'd like to discuss this with other subscribers or get access...
It’s Pretty Bad: Andy Brooks of RUCDR on Sample Quality
19 Mar 2015
Contributed by Lukas
The future of diagnostics is in the hands of those taking care of the biospecimen samples says, Andy Brooks our final guest in the series, Improving B...
Knowing More about What We Don’t Know: John McPherson on Cancer Genomics
17 Mar 2015
Contributed by Lukas
More than with any other major disease, the understanding and treatment of cancer is being transformed by genomics. And these are early days.John McP...
Gene and Tonic: The iWatch and Research Kit, 23andMe Goes for the Big Time, No Spaceship
13 Mar 2015
Contributed by Lukas
Friday March 13thIt’s Friday already and time for Gene and Tonic, our wrap of the week’s headlines.On Monday, Apple’s CEO, Tim Cook, announced t...
In Partnership with IBM’s Watson, Pathway Genomics Reinvents Itself
12 Mar 2015
Contributed by Lukas
Direct-to-consumer (DTC) genetic testing has had a bumpy ride.Back in 2010, Pathway Genomics and Walgreens made a deal to sell DTC genetic tests in th...
Affymetrix CEO, Frank Witney, on Arrays in the Age of Sequencing
10 Mar 2015
Contributed by Lukas
Go about anywhere in the life science industry, and you’ll run into someone who once worked at Affymetrix. Since the founding of Affymetrix and the...
Gene & Tonic: Disruption in Sequencing, Scientist Politicians, Some Cool Synbio
06 Mar 2015
Contributed by Lukas
Join Theral for a quick wrap-up of the week's biotech news:The biggest news this week has been the flow of stories coming from last week’s AGBT con...